Actobiochem, a subsidiary of Actover Holding, was established to produce Active Pharmaceutical Ingredients (API) and drive advancements in Iran’s pharmaceutical industry. By leveraging cutting-edge technology, Actobiochem supplies APIs for Actover’s medicines and supports other Iranian pharmaceutical companies in improving the quality of their products to meet global standards.
In recent years, responding to Actoverco’s needs and the demands of the Iranian market, Actobiochem has expanded its expertise to include the production of finished pharmaceutical products. This strategic step has enabled the company to play a significant role in delivering high-quality medicines to the local and international markets.
Actobiochem’s products cover a wide range of therapeutic areas, including cardiovascular, diabetes, oncology, hormonal, and anti-allergic medications. By prioritizing innovation and quality, Actobiochem contributes to the growth of Iran’s pharmaceutical sector, empowering the country to achieve global recognition in the industry.
Please provide your collaboration proposal details in the form below. Our team will contact you after review.
Actobiochem, a prominent subsidiary of Actover Holding, proudly participated in the International Pharmex Exhibition, one of the most significant global events in the pharmaceutical industry. This exhibition provided a unique platform to showcase advancements and innovations in Active Pharmaceutical Ingredient (API) production. Actobiochem presented its diverse range of products in key therapeutic areas such as […]
20 Minutes
Actobiochem, a distinguished subsidiary of Actover Holding, not only participated in the International Pharmex Exhibition but also proudly received a prestigious award for its outstanding contributions to the pharmaceutical industry. This recognition highlights the company’s innovative advancements in the production of Active Pharmaceutical Ingredients (API) and its commitment to excellence. The award acknowledges Actobiochem’s achievements […]
Actobiochem, a leading player in Iran’s pharmaceutical industry, organized a specialized panel on “Pharmaceutical and Medical Bioterrorism” in collaboration with health sector professionals during the Iran Health International Exhibition 2023. The event, held on May 20, 2023, aimed to address the threats posed by bioterrorism in the pharmaceutical and medical sectors and to explore the […]
Actobiochem, a subsidiary of Actover Holding, was established to produce Active Pharmaceutical Ingredients (API) and has succeeded in driving advancements in Iran’s pharmaceutical industry.
All rights reserved by Actobiochem Pharmaceutical Compony.
"Actobiochem, as a key subsidiary of Actover Group, has demonstrated remarkable dedication and expertise in advancing our shared mission. Their tireless efforts in producing high-quality APIs have significantly contributed to the overall success and innovation of Actover Group. We value and appreciate their commitment to excellence."